Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind? - The Cancer

. 2015 Jan-Feb;41(1):5-9.

doi: 10.1590/S1677-5538.IBJU.2015.01.02.

Rodrigo Donalisio da Silva¹, Fernando J Kim^{1

2}

Affiliations

¹ Division of Urology, Department of Surgery, Denver Health Medical Center, University of Colorado School of Medicine, Denver CO, USA.
² University of Colorado Cancer Center, UC Denver. Denver CO, USA.

Rodrigo Donalisio da Silva et al. Int Braz J Urol. 2015 Jan-Feb.

. 2015 Jan-Feb;41(1):5-9.

doi: 10.1590/S1677-5538.IBJU.2015.01.02.

Rodrigo Donalisio da Silva¹, Fernando J Kim^{1

2}

¹ Division of Urology, Department of Surgery, Denver Health Medical Center, University of Colorado School of Medicine, Denver CO, USA.
² University of Colorado Cancer Center, UC Denver. Denver CO, USA.

No abstract available

Cited by

Prostate Cancer - Local Treatment after Radiorecurrence: Salvage Cryoablation.
da Silva RD, Kim FJ. da Silva RD, et al. Int Braz J Urol. 2018 May-Jun;44(3):435-439. doi: 10.1590/S1677-5538.IBJU.2018.03.05. Int Braz J Urol. 2018. PMID: 29792652 Free PMC article. No abstract available.

1. Neppl-Huber C, Zappa M, Coebergh JW, Rapiti E, Rachtan J, Holleczek B, et al. Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths. Ann Oncol. 2012;23:1325–1334. - PubMed
1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Câncer statistics, 2006. CA Cancer J Clin. 2006;56:106–130. - PubMed
1. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. European Association of Urology. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65:124–137. - PubMed
1. Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS, et al. AUA Prostate Cancer Clinical Guideline Update Panel. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177:2106–2131. - PubMed
1. Carter CA, Donahue T, Sun L, Wu H, McLeod DG, Amling C, et al. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era. J Clin Oncol. 2003;21:4001–4008. - PubMed